The generation of high-affinity antibodies against pathogens and vaccines requires the germinal center (GC) reaction, which relies on a complex interplay between specialized effector B and CD4 T lymphocytes, the GC B cells and T follicular helper (TFH) cells. Intriguingly, several positive key regulators of the GC reaction are common for both cell types. Here, we report that the transcription factor Bhlhe40 is a crucial cell-intrinsic negative regulator affecting both the B and T cell sides of the GC reaction. In activated CD4 T cells, Bhlhe40 was required to restrain proliferation, thus limiting the number of TFH cells. In B cells, Bhlhe40 executed its function in the first days after immunization by selectively restricting the generation of the earliest GC B cells but not of early memory B cells or plasmablasts. Bhlhe40-deficient mice with progressing age succumbed to a B cell lymphoma characterized by the accumulation of monoclonal GC B-like cells and polyclonal TFH cells in various tissues.
Skip Nav Destination
Article navigation
7 February 2022
Article|
December 17 2021
Bhlhe40 function in activated B and TFH cells restrains the GC reaction and prevents lymphomagenesis
In Special Collection:
Immunology Update Winter 2022
René Rauschmeier
,
(Conceptualization, Formal analysis, Investigation, Project administration, Resources, Visualization)
1
Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria
Search for other works by this author on:
Annika Reinhardt
,
2
Department of Medicine, Division of Immunology and Allergy, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
3
Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
Search for other works by this author on:
Charlotte Gustafsson
,
Charlotte Gustafsson
(Investigation)
4
Center for Hematology and Regenerative Medicine, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
Search for other works by this author on:
Vassilis Glaros
,
Vassilis Glaros
(Formal analysis, Investigation, Validation, Visualization)
2
Department of Medicine, Division of Immunology and Allergy, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
3
Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
Search for other works by this author on:
Artem V. Artemov
,
Artem V. Artemov
(Data curation, Formal analysis, Software, Visualization)
5
Department of Neuroimmunology, Medical University of Vienna, Vienna, Austria
6
Endocrinology Research Centre, Moscow, Russian Federation
Search for other works by this author on:
Josefine Dunst
,
Josefine Dunst
(Investigation)
2
Department of Medicine, Division of Immunology and Allergy, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
3
Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
Search for other works by this author on:
Reshma Taneja
,
Reshma Taneja
(Resources)
7
Department of Physiology, Healthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Search for other works by this author on:
Igor Adameyko
,
Igor Adameyko
(Resources, Software, Supervision)
5
Department of Neuroimmunology, Medical University of Vienna, Vienna, Austria
8
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
Search for other works by this author on:
Robert Månsson
,
Robert Månsson
(Conceptualization, Investigation, Methodology, Resources, Supervision)
4
Center for Hematology and Regenerative Medicine, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
9
Hematology Center, Karolinska University Hospital, Stockholm, Sweden
Search for other works by this author on:
Meinrad Busslinger
,
(Conceptualization, Funding acquisition, Project administration, Supervision, Writing - original draft)
1
Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria
Meinrad Busslinger: Meinrad.Busslinger@imp.ac.at
Search for other works by this author on:
Taras Kreslavsky
(Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Project administration, Supervision, Visualization, Writing - original draft, Writing - review & editing)
2
Department of Medicine, Division of Immunology and Allergy, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
3
Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
Correspondence to Taras Kreslavsky: Taras.Kreslavskiy@ki.se
Search for other works by this author on:
René Rauschmeier
Conceptualization, Formal analysis, Investigation, Project administration, Resources, Visualization
1
Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria
2
Department of Medicine, Division of Immunology and Allergy, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
3
Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
Charlotte Gustafsson
Investigation
4
Center for Hematology and Regenerative Medicine, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
Vassilis Glaros
Formal analysis, Investigation, Validation, Visualization
2
Department of Medicine, Division of Immunology and Allergy, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
3
Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
Artem V. Artemov
Data curation, Formal analysis, Software, Visualization
5
Department of Neuroimmunology, Medical University of Vienna, Vienna, Austria
6
Endocrinology Research Centre, Moscow, Russian Federation
Josefine Dunst
Investigation
2
Department of Medicine, Division of Immunology and Allergy, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
3
Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
Reshma Taneja
Resources
7
Department of Physiology, Healthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Igor Adameyko
Resources, Software, Supervision
5
Department of Neuroimmunology, Medical University of Vienna, Vienna, Austria
8
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
Robert Månsson
Conceptualization, Investigation, Methodology, Resources, Supervision
4
Center for Hematology and Regenerative Medicine, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden
9
Hematology Center, Karolinska University Hospital, Stockholm, Sweden
Meinrad Busslinger
Conceptualization, Funding acquisition, Project administration, Supervision, Writing - original draft
1
Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria
Taras Kreslavsky
Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Project administration, Supervision, Visualization, Writing - original draft, Writing - review & editing
2
Department of Medicine, Division of Immunology and Allergy, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
3
Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
Correspondence to Taras Kreslavsky: Taras.Kreslavskiy@ki.se
Meinrad Busslinger: Meinrad.Busslinger@imp.ac.at
Disclosures: The authors declare no competing interests exist.
*
R. Rauschmeier and A. Reinhardt contributed equally to this paper.
Received:
June 30 2021
Revision Received:
November 01 2021
Accepted:
November 23 2021
Online Issn: 1540-9538
Print Issn: 0022-1007
Funding
Funder(s):
Swedish Research Council
- Award Id(s): 2017-01118,2018-05973
Funder(s):
Cancerfonden
- Award Id(s): CAN 2018/710
Funder(s):
Åke Wiberg Stiftelse
- Award Id(s): M18-0094
Funder(s):
Austrian Science Fund
- Award Id(s): P28841
Funder(s):
Wenner-Gren Foundation
Funder(s):
German Research Foundation
- Award Id(s): DU 1964/1-1,RE 4264/1-1
Funder(s):
Boehringer Ingelheim
Funder(s):
European Research Council
Funder(s):
Horizon 2020
- Award Id(s): 740349-PlasmaCellControl
Funder(s):
Ministry of Science and Higher Education of the Russian Federation
- Award Id(s): 075-15-2020-784
© 2021 Rauschmeier et al.
2021
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
J Exp Med (2022) 219 (2): e20211406.
Article history
Received:
June 30 2021
Revision Received:
November 01 2021
Accepted:
November 23 2021
Connected Content
Commentary
Bhlhe40: Gatekeeper of the GC
Citation
René Rauschmeier, Annika Reinhardt, Charlotte Gustafsson, Vassilis Glaros, Artem V. Artemov, Josefine Dunst, Reshma Taneja, Igor Adameyko, Robert Månsson, Meinrad Busslinger, Taras Kreslavsky; Bhlhe40 function in activated B and TFH cells restrains the GC reaction and prevents lymphomagenesis. J Exp Med 7 February 2022; 219 (2): e20211406. doi: https://doi.org/10.1084/jem.20211406
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Sign in via your Institution
Sign in via your Institution
1,851
Views
0
Citations
Advertisement